Head of Central Bank explains why banks do not lower lending rates following cuts in refinancing rate

YEREVAN , March 18. /ARKA/. The head of the Armenian Central Bank Martin Galstyan explained why banks do not lower lending rates in response to the reductions of the refinancing rate.

On March 18, the Central Bank Board left the refinancing rate unchanged at 6.75%. This was the first time since June 2023 that the refinancing rate has remained unchanged. From June 2023 to February 2025, the refinancing rate was reduced from 10.75% to 6.75%.

“Interest rates on loans depend on supply and demand. If we see that some bank product has a huge demand due to other reasons, particularly, government policy in the mortgage market, it does not allow us to adjust the rates in terms of reduction,” Galstyan said.

According to him, the internal structure of the banks’ loan portfolio also affects the interest rates on loans – the share of consumer loans, the interest on which is higher, is growing. Since these loans are granted in Armenian drams, the weighted average interest rate is rising.

“If the demand for loans drops, we may see a decrease in interest rates on loans,” Galstyan said.

The loan portfolio of Armenia-based banks increased by AMD 1.2 billion or 24% to AMD 6.4 billion in 2024, including 1.4 trillion of consumer loans (33% growth for the year).

Mortgage credits account for almost the same amount, 32.9% growth over the year. The construction sector accounted for 10.4% (660.5 billion drams, 32.7% growth).

During 2024, interest rates on both AMD and foreign currency loans decreased. Rates on AMD loans from 1 to 5 years decreased by 0.7 p.p., the average interest rate at the end of the year amounted to 16.7%. Rates on loans in foreign currency decreased by 1.5 p.p., to 9.8%. -0-

spot_img

POPULAR

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

“AGROVISION” CJSC’s bonds were listed on Armenia Stock Exchange

YEREVAN, August 17. /ARKA/.  Today, “AGROVISION” CJSC, a company operating in the agro-industrial sector, became a listed company on the Armenia Stock Exchange (AMX).

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

LATEST NEWS

spot_imgspot_imgspot_img